Why Is Multifocal Motor Neuropathy Often Misdiagnosed?

Getting a diagnosis of Multifocal Motor Neuropathy (MMN) is often a long, frustrating journey. Studies show that patients often wait anywhere from two to over five years from their first symptoms to a final answer, and more than half wait over a year even after seeing a neurologist ^[1][2][3]. This diagnostic delay happens for three main reasons: MMN is an extremely rare disease, its early symptoms closely mimic more common conditions, and the complex nerve tests required to support the diagnosis are technically difficult to perform and interpret ^[2][4][5].

Important: If you experience sudden or rapidly progressive weakness, new trouble breathing or swallowing, severe new neck or back pain, or new bowel or bladder issues, seek urgent medical assessment rather than waiting for routine nerve testing.

A Rare Disease That Looks Like Other Conditions

MMN affects roughly 1 or 2 people per 100,000 ^[2][6]. Because most doctors rarely see a case, they first look for more common conditions. MMN typically causes slowly progressive, asymmetric (uneven) weakness, usually starting in the hands, wrists, or lower arms, with little to no numbness or sensory loss ^[7]. This pattern can be mistaken for:

• Nerve Entrapment Syndromes: Because weakness is often focal, it is frequently mistaken for common localized pinched nerves ^[7]. Patients might be told they have carpal tunnel syndrome, ulnar neuropathy, or a pinched radial nerve ^[8][9].
• Amyotrophic Lateral Sclerosis (ALS): MMN and ALS can both cause progressive limb weakness and fasciculations (visible muscle twitches) ^[4][7]. However, MMN typically lacks upper motor neuron signs (symptoms like very stiff muscles or hyperactive reflexes), which are more common in ALS ^[10][11]. While the absence of these signs does not entirely rule out ALS early on, distinguishing between the two is critical because MMN is often responsive to treatment ^[4].
• Other Conditions: Doctors may also need to rule out cervical radiculopathy (a pinched nerve in the neck), other rare neuropathies like MADSAM (which includes sensory loss), or hereditary motor conditions ^[12].

Comparing the Symptoms

(Note: This table is a general educational guide, not a diagnostic tool.)

The Challenges of Nerve Testing

To help diagnose MMN, neurologists use an electromyogram and nerve conduction study (EMG/NCS) to look for a highly specific finding called motor conduction block. This means there is a focal drop in the electrical signal’s size (amplitude) as it travels down the nerve at areas where the nerve is not being compressed ^[7][11].

Finding a true conduction block can be difficult:

• Hidden locations: The block might be located in proximal nerves closer to the neck or shoulder, where routine testing cannot easily reach ^[13][14].
• Temporal dispersion: Sometimes the electrical response is widened or scattered over time (temporal dispersion). This is a distinct finding that can confound the interpretation of the test and make it hard to confirm a true block ^[5][15].
• Axonal loss: Over time, damage to the nerve fiber itself (axonal loss) can lower the overall electrical signal, masking the block ^[5].

Because these tests are complex, a normal or unclear study does not automatically rule out MMN ^[5][16]. However, this does not mean every negative test is wrong; rather, a neuromuscular specialist will interpret the results based on established diagnostic criteria, the overall clinical picture, and sometimes by testing additional nerves ^[14][15].

Blood Tests and Treatment Trials

Many patients with MMN have elevated levels of IgM Anti-GM1 antibodies (immune system proteins associated with nerve membranes). However, these are present in only about 40% to 50% of MMN patients ^[1][2]. A positive test supports the diagnosis but is not proof of MMN on its own, and a negative test does not rule it out ^[14].

When the diagnosis is strongly suspected based on clinical and electrodiagnostic evidence, specialists may suggest a monitored trial of intravenous immunoglobulin (IVIg) ^[3]. IVIg is a prescription treatment with costs and risks, and it is not a diagnostic test. However, while it is not a cure and established axonal damage may not fully recover, a positive response (improving or stabilizing strength) can further support the diagnosis ^[3][17].